A detailed morphologic and immunohistochemical comparison of pre- and postmenopausal endometriosis

Journal of Clinical Pathology

Volumn 61, Issue 4, 2008, Pages 455-459

  Cumiskey, J ^a   Whyte, P ^a   Kelehan, P ^a   Gibbons, D ^a  

^a NATIONAL MATERNITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ENDOMETRIOSIS; EPITHELIUM; FEMALE; HUMANS; MIDDLE AGED; NEPRILYSIN; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; STROMAL CELLS;

EID: 42049086970     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.050971     Document Type: Article

References (14)

1. Robboy SJ, Anderson MC, Russell P. Endometriosis. In: Robboy SJ, Anderson MC, Russell P, eds. Pathology of the female reproductive tract. London, UK: Churchill Livingstone, 2002
2. Shaw RW. Endometriosis. In: Shaw RW, Soutter P, Stanton SL, eds. Gynaecology. New York, USA: Churchill Livingstone, 1992.
3. McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001;39:273- 8.
4. Toki T, Shimizu M, Takagi Y, et al. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol 2002;21:41-7.
5. Sumathi VP, McCluggage. CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis. J Clin Pathol 2002;55:391-2.
6. Toki T, Horiuchi A, Li SF, et al. Proliferative activity of postmenopausal endometriosis: a histopathologic and immunohistochemical study. Int J Gynecol Pathol 1996;15:45-53.
7. Santell RC, Chang YC, Nair MG, et al. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 1997;127:263-9.
8. Cotroneo MS, Lamartiniere CA. Pharmacologic, but not dietary, genistein supports endometriosis in a rat model. Toxicol Sci 2001;61:68-75.
9. Stern RC, Dash R, Bentley RC, et al. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 2001;20:133-9.
10. Brinton LA, Gridley G, Persson I, et al. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-9.
11. Brooks JJ, Wheeler JE. Malignancy arising in extragonadal endometriosis: a case report and summary of the world literature. Cancer 1977;40:3065-73.
12. DePriest PD, Banks ER, Powell DE, et al. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol 1992;47:71-5.
13. Bergqvist A, Rannevik G, Thorell J. Estrogen and progesterone cytosol receptor concentration in endometriotic tissue and intrauterine endometrium. Acta Obstet Gynecol Scand Suppl 1981;101:53-8.
14. Gould SF, Shannon JM, Cunha GR. Nuclear estrogen binding sites in human endometriosis. Fertil Steril 1983;39:520-4.